Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

AI In Bioinformatics Market Growth Potential: How Will Market Size Change Through 2030?

The market for AI in bioinformatics has experienced tremendous expansion over the last several years. Starting at $6.14 billion in 2025, it is projected to reach $8.81 billion by 2026, achieving a compound annual growth rate (CAGR) of 43.6%. This historical growth has been driven by factors such as the increasing amount of genomic data, the widespread uptake of next-generation sequencing technologies, greater financial support for bioinformatics research, the early incorporation of machine learning within the life sciences sector, and the ongoing enlargement of public biological databases.

The AI in bioinformatics sector is projected to undergo remarkable expansion in the coming years, with its value anticipated to reach $37.63 billion by 2030, representing a compound annual growth rate (CAGR) of 43.7%. This projected growth during the forecast period is driven by several key factors, including the heightened necessity for precision medicine, the growing application of artificial intelligence in clinical decision-making support systems, increased investments in pharmaceutical research and development, progress made in deep learning frameworks, and an escalating requirement for expedited drug development timelines. Among the prominent developments shaping this future period are the interpretation of genomic data through AI mechanisms, the automation of drug discovery processes and target identification, the incorporation of platforms that handle multi-omics data, the adoption of cloud-centric workflows for bioinformatics, and the implementation of advanced predictive models focused on protein structure analysis.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13774&type=smp

AI In Bioinformatics Market Development Factors: Which Trends Are Supporting Demand?

Major players within the AI in bioinformatics market include Dassault Systèmes SE, QIAGEN N.V., SomaLogic Operating Co. Inc., Seven Bridges Genomics Inc., Genialis Inc., SOPHiA GENETICS SA, DNAnexus Inc., Insilico Medicine Inc., Deep Genomics Inc., Biomax Informatics Inc., Ardigen SA, Strand Life Sciences Pvt. Ltd., Genomenon Inc., Fios Genomics Limited, BlueBee Holding BV, JADBio, Elucidata Corporation, Gnosis DA, DNASTAR Inc., iNDX.Ai, and Paige AI Inc.

AI In Bioinformatics Market Segment Breakdown: Which Categories Generate The Most Revenue?

The artificial intelligence clinical trial protocol feasibility tool market covered in this report is segmented –

1) By Component: Software, Services

2) By Deployment Mode: Cloud-Based, On-Premises

3) By Application: Protocol Design, Site Selection, Patient Recruitment, Risk Assessment, Other Applications

4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Software: Predictive Analytics, Machine Learning, Natural Language Processing, Data Integration

2) By Services: Consulting, Implementation, Training And Support, Managed Services

AI In Bioinformatics Market Transformation Trends: Which Innovations Are Driving Change?

Seqera has completed the acquisition of Tinybio, an AI-focused bioinformatics startup, in a move designed to strengthen its platform for the life sciences sector.

AI In Bioinformatics Market Key Players And Strategic Industry Positioning

Major companies operating in the artificial intelligence clinical trial protocol feasibility tool market are IQVIA Holdings Inc., SAS Institute Inc., Veeva Systems Inc., Tempus AI Inc., Cytel Inc., ArisGlobal LLC., Saama Technologies Inc., Norstella, ConcertAI, Komodo Health Inc., H1 Inc., TriNetX Inc., ObjectiveHealth LLC, Lokavant Inc., Inato Inc., Clinerion Ltd., Faro Health Inc., Lantern Pharma Inc., Ryght AI, BEKHealth Corporation

Access The Complete AI In Bioinformatics Market Report:

https://www.thebusinessresearchcompany.com/report/ai-in-bioinformatics-global-market-report

AI In Bioinformatics Market Geographic Analysis: Where Is Demand Growing The Fastest?

North America was the largest region in the artificial intelligence clinical trial protocol feasibility tool market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence clinical trial protocol feasibility tool market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized AI In Bioinformatics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=27204&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model